S1166 Serum Interleukin 17 Levels in Ulcerative Colitis and Crohn's Disease: Inflammatory Bowel Disease Patients in Indonesia

Muhammad F. Prananda,Murdani Abdullah,Sukamto Koesnoe,Robert Sinto
DOI: https://doi.org/10.14309/01.ajg.0001034032.45319.9f
2024-10-26
The American Journal of Gastroenterology
Abstract:The incidence of inflammatory bowel disease (IBD) is increasing worldwide, with different characteristics in each country. IL-17 is a strong pro-inflammatory cytokine that plays a role in IBD. No studies have assessed serum interleukin 17 (IL-17) levels in IBD patients in Indonesia, which can reveal its role in the pathogenesis of IBD as well as proposed therapeutic modalities for IBD. This study aimed to determine the difference in serum IL-17 levels in patients with IBD.
gastroenterology & hepatology
What problem does this paper attempt to address?